Whole blood FPR1 mRNA expression predicts both non‐small cell and small cell lung cancer

While long‐term survival rates for early‐stage lung cancer are high, most cases are diagnosed in later stages that can negatively impact survival rates. We aim to design a simple, single biomarker blood test for early‐stage lung cancer that is robust to preclinical variables and can be readily imple...

Descripción completa

Detalles Bibliográficos
Autores principales: Morris, Scott, Vachani, Anil, Pass, Harvey I., Rom, William N., Ryden, Kirk, Weiss, Glen J., Hogarth, D. K., Runger, George, Richards, Donald, Shelton, Troy, Mallery, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Tumor Markers and Signatures
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901395/
https://www.ncbi.nlm.nih.gov/pubmed/29313979
http://dx.doi.org/10.1002/ijc.31245

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5901395/
https://www.ncbi.nlm.nih.gov/pubmed/29313979
http://dx.doi.org/10.1002/ijc.31245

Ejemplares similares